Companies: 10,795·Total market cap: $144.5T
United Therapeutics Corporation

United Therapeutics Corporation

UTHRNASDAQHealthcare● Active
$551.80
+$1.93(+0.35%)
Market Cap$23.4B
P/E Ratio
52W High$609.35
52W Low$272.12

United Therapeutics Corporation(UTHR)· 损益表

年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q(经 FMP 聚合)· 可在下方切换周期与 M/B/T 单位。

FMP · UTHR · 截至 2026-06-08

财务报表

Revenue · Gross Profit · Net Income
Breakdown2025-122024-122023-122022-122021-12
Revenue
Revenue$3.18B$2.88B$2.33B$1.94B$1.69B
Cost of Revenue$0.38B$0.31B$0.26B$0.15B$0.12B
Gross Profit$2.80B$2.57B$2.07B$1.79B$1.56B
Gross Margin %(computed)87.92%89.24%88.94%92.42%92.73%
Operating Expenses
R&D Expenses$0.55B$0.48B$0.41B$0.32B$0.54B
G&A Expenses$0.61B$0.54B$0.40B$0.42B$0.40B
Total Operating Expenses$1.28B$1.19B$0.89B$0.81B$1.01B
Operating Income$1.52B$1.38B$1.18B$0.98B$0.56B
Operating Margin %(computed)47.67%47.86%50.91%50.60%32.98%
Interest Income$0.19B$0.20B$0.16B$0.05B$0.02B
Interest Expense$0.02B$0.04B$0.06B$0.03B$0.02B
Income Before Tax$1.71B$1.54B$1.27B$0.95B$0.59B
Income Tax Expense$0.38B$0.34B$0.29B$0.22B$0.12B
Net Income$1.33B$1.20B$0.98B$0.73B$0.48B
Net Margin %(computed)41.94%41.53%42.31%37.56%28.23%
Per Share & EBITDA
EPS (Basic)$30.13$26.44$21.04$15.98$10.60
Wtd Avg Shares0.04B0.05B0.05B0.05B0.04B
EBITDA$1.82B$1.65B$1.39B$1.04B$0.74B
EBITDA Margin %(computed)57.15%57.50%59.58%53.73%43.71%

数据来源:Financial Modeling Prep · 最后更新:2026-06-08 · USD · B

深入了解United Therapeutics Corporation

关于United Therapeutics Corporation(UTHR)损益表

United Therapeutics Corporation(UTHR)损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年,UTHR实现营收$3.18B,毛利润$2.80B(毛利率87.92%),净利润$1.33B(净利率41.94%)。

常见问题

UTHR · 4 问

United Therapeutics Corporation(UTHR)2025财年营收为$3.18B,同比up10.6%。

UTHR revenueUTHR salesannual revenue YoYincome statement

· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08